tm
Seeing Is Believing
tm
Seeing Is Believing
BEAM is currently covered by 8 analysts with an average potential upside of $26.22 (48.1%) from yesterday's end of day stock price of $26.4. Beam Therapeutics activity chart has currently 8 price targets and 23 ratings on display.
Analysts average stock forecasts to be materialized ratio is 26.53% with an average time for these price targets to be met of 41.58 days.
Highest price target for BEAM is $78, Lowest price target is $26, average price target is $52.
Most recent stock forecast was given by RICK BIENKOWSKI from CANTOR FITZGERALD on 13-Sep-2023. First documented stock forecast 29-Jan-2021.
Currently, out of the existing stock ratings of BEAM - 12 which are a Hold (70.59%), 5 which are a Buy (29.41%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
56
$31.95 (132.85%)
56
2 months 26 days ago
0/8 (0%)
$38.28 (91.47%)
Hold
35
$8.6 (32.58%)
41
4 months ago
3/5 (60%)
$-15.92 (-9.20%)
191
Hold
47
$20.6 (78.03%)
47
4 months ago
1/4 (25%)
$16.17 (47.89%)
82
Buy
55
$28.6 (108.33%)
150
6 months 24 days ago
0/2 (0%)
$30.04 (45.26%)
Hold
42
$15.6 (59.09%)
85
6 months 28 days ago
1/2 (50%)
$8.32 (16.22%)
35
What is BEAM (Beam Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on BEAM (Beam Therapeutics) with a proven track record?
Which analyst has the most public recommendations on BEAM (Beam Therapeutics)?
Which analyst is the currently most bullish on BEAM (Beam Therapeutics)?
Which analyst is the currently most reserved on BEAM (Beam Therapeutics)?
